pci

doble antiagregacion plaquetaria sexo

Dual Antiplatelet Therapy in Men and Women: Are There Differences?

Courtesy of Dr. Agustín Vecchia.   Currently, the duration of dual antiplatelet therapy (DAPT) after stent placement is one of the most highly debated topics in Cardiology. On the one hand, women are usually underrepresented in trials in our specialty; on the other, the fact that symptoms of coronary disease are different in women is well-known.   The aim...

DES: Best Option in Saphenous Vein Grafts

These results confirm that, despite being used less and less worldwide, DES (drug eluting stents) are the best option in saphenous vein grafts.   Saphenous vein graft atherosclerosis has a different pathophysiology to that of native arteries, and PCI in this context is less effective because of high risk of friable thromboembolic material, faster plaque...

OCT Improves Outcomes in Non ST Elevation ACS

This study presented at the ESC and simultaneously published in Circulation, is the first randomized controlled study to support the use of optical coherence tomography (OCT) in the context of ACS patients.   The study randomized 240 patients undergoing non ST elevation acute coronary syndrome to OCT guided PCI (before and after PCI) vs. conventional...

isquemia crítica de miembros inferiores

Angiosome: Is It Feasible in Critical Limb Ischemia?

Courtesy of Dr. Carlos Fava.   Critical limb ischemia (CLI) accompanied by tissue loss entails high risk of amputation. At present, there is substantial evidence in favor of revascularization by PCI according to the angiosome concept, but the feasibility of this treatment remains unclear.   161 compromised limbs were analyzed in 160 patients with foot...

cangrelor vs. clopidogrel infartos peri-procedimiento

Peri-Procedural MI Reduction: Cangrelor or Clopidogrel?

Cangrelor is an intravenous P2Y12 inhibitor approved to reduce peri-procedural ischemic events in patients undergoing PCI that have not previously received any other P2Y12 inhibitor.   The CHAMPION PHOENIX trial randomized a total of 11,145 patients to cangrelor vs. clopidogrel.   The study sought to explore the effect of cangrelor on peri-procedural acute myocardial infarction...

TDAP duración óptima

Optimal Duration of DAPT: How to Predict Long-Term Events

Courtesy of Dr. Santiago F. Coroleu.   Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel after percutaneous coronary intervention (PCI) reduces the risk for coronary thrombotic events (CTEs) at the expense of increasing risk for major bleeding (MB). However, the lack of information to accurately predict the occurrence of each event in out-of-hospital patients under...

cierre percutaneo femoral

Closure Devices vs. Manual Compression

Courtesy of Dr. Guillermo Migliaro.   Post PCI major bleeding has been associated with short term mortality in acute coronary syndromes (ACS). Even though studies have shown the transradial approach is safer than the femoral, especially in high risk subgroups ─ mainly STEMI patients ─ the femoral access site continues to be widely used.  ...

sbhci_CTO2016

Chronic Total Occlusion Summit in Brazil

  Save the Date: Septiembre 2nd. and 3rd. Pullman Ibirapuera – São Paulo Room. Organiza: SBHCI. SBHCI, with SOLACI’s support, invites you to participate of the CTO Summit, that will take place on September 2nd and 3rd, 2016 in San Paulo, Brazil.                   Schedule: SEPTEMBER 2ND   08h30 –...

balon no complaciente

Non-Compliant Balloons Improve Bifurcation Outcomes

Courtesy of Dr. Carlos Fava. The provisional approach is the standard strategy to treat bifurcations, but it might cause dissection of the ostium, a serious complication of the side branch. The use of non-compliant balloons (NCB) ensures uniform, constant, and controlled expansion along balloon length, reducing the risk of dissection. The COBIS II registry enrolled...

acceso_radial_final

All-Spectrum Transradial Approach: Safer than Femoral

Original Title: Radial vs femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials. Reference: Ferrante G et al. J Am Coll Cardiol Intv. 2016; Epub ahead of print.   Regardless the type of coronary syndrome, the transradial approach results in lower mortality and complications...

Top